. Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants. Brain. 2023 Oct 3;146(10):e75-e76. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.